GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CARISMA Therapeutics Inc (FRA:W2J) » Definitions » Purchase Of Property, Plant, Equipment

CARISMA Therapeutics (FRA:W2J) Purchase Of Property, Plant, Equipment : €-0.63 Mil (TTM As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is CARISMA Therapeutics Purchase Of Property, Plant, Equipment?

CARISMA Therapeutics's purchase of property, plant, equipment for the three months ended in Sep. 2024 was €0.00 Mil. It means CARISMA Therapeutics spent €0.00 Mil on purchasing property, plant, equipment. CARISMA Therapeutics's purchase of property, plant, equipment for the trailing twelve months (TTM) ended in Sep. 2024 was €-0.63Mil.

Compared with last quarter (€-0.10 Mil in Jun. 2024 ), CARISMA Therapeutics spent less money on purchasing property, plant, equipment in Sep. 2024 (€0.00 Mil).

CARISMA Therapeutics Purchase Of Property, Plant, Equipment Historical Data

The historical data trend for CARISMA Therapeutics's Purchase Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CARISMA Therapeutics Purchase Of Property, Plant, Equipment Chart

CARISMA Therapeutics Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Purchase Of Property, Plant, Equipment
-0.36 -1.66 -4.40 -1.04

CARISMA Therapeutics Quarterly Data
Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Purchase Of Property, Plant, Equipment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.18 -0.51 -0.02 -0.10 -

CARISMA Therapeutics Purchase Of Property, Plant, Equipment Calculation

The amount used to purchase PPE.

Purchase Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.63 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CARISMA Therapeutics Purchase Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of CARISMA Therapeutics's Purchase Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.

CARISMA Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CARISMA Therapeutics Inc (FRA:W2J) » Definitions » Purchase Of Property, Plant, Equipment
Comparable Companies
TSVT PLX CDXS TALS ABSI DSGN PEPG TRVI ADAP CTXR OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
CARM:USA W2J:Germany
Address
3675 Market Street, Suite 200, Philadelphia, PA, USA, 19104
Website
https://www.carismatx.com
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.

CARISMA Therapeutics Headlines

No Headlines